Brian Lian, President & CEO at Viking Therapeutics, Inc. (VKTX), sold 598,704 shares at $16.95 ($10.4M) on 2023-03-30, disclosed to the SEC on 2023-04-03.
Open-market sale of $10.4M VKTX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.95 | 88,000 | $1.5M | 14.3% |
| 2 | $17.45 | 65,382 | $1.1M | 10.9% |
| 3 | $17.45 | 65,382 | $1.1M | 10.9% |
| 4 | $17.45 | 67,970 | $1.2M | 11.4% |
| 5 | $17.45 | 67,970 | $1.2M | 11.4% |
| 6 | $17.57 | 200,000 |
| $3.5M |
| 33.6% |
| 7 | $17.85 | 22,000 | $393K | 3.8% |
| 8 | $17.85 | 22,000 | $393K | 3.8% |
| Total | $17.45 avg | 598,704 | $10.4M | 100% |
| Filing → |
| VKTX | SELL | 2025-10-28 | $2.7M | — | Filing → |
| VKTX | SELL | 2025-07-03 | $1.5M | — | Filing → |
| VKTX | SELL | 2025-01-06 | $15.8M | — | Filing → |